Colette Hall, M.D.
Dr. Hall has served as the Vice President of Medical and Safety at Clearside Biomedical since January 2020 and as Vice President of Safety from 2018 to 2020. As Vice President of Medical and Safety, she is responsible for leading the global pharmacovigilance strategy and execution relating to all clinical and product development initiatives.
Previously, she served as a Medical Safety Advisor at IQVIA where she led both clinical and safety teams for over 90 companies, executing over 100 protocols across multiple indications. Prior to IQVIA, she maintained a solo primary care practice where she successfully managed and provided medical care to over 2500 patients. She also served as a Principal Investigator on various clinical trials during that time. Dr. Hall maintains U.S. Board certification in Internal Medicine, is a licensed physician for the state of Georgia, and is an active member of the American Medical Association and American College of Physicians. She holds a M.D. degree from Meharry Medical College and a B.S. degree in Biology from Duke University.